7th Annual Spring to Life Conference on Lung Cancer

Albany, NY | April 18, 2020

PROUDLY SPONSORED BY:

DATE/LOCATION

April 18, 2020
Albany Marriott Hotel
189 Wolf Road
Albany, NY 12205

Registration

Please click here if you would like to be notified when registration is open. We hope to see you in 2020!

Goal

Spring to LifeTM Conference on Immuno-Oncology: Harnessing the Power of our Immune System in Cancer Therapy is an accredited educational program developed by New York Oncology Hematology (NYOH), in collaboration with the Center for Emergency Medical Education (CEME), the Leukemia & Lymphoma Society, and a panel of expert faculty from the academic, research, and community practice settings.

OVERVIEW

With programming for both healthcare professionals and the community, the goal of this 1-day activity is to bring together cancer care providers and members of the community, including patients, survivors, their family, and caregivers, to gain an up-to-date understanding of blood cancers, including ongoing research, clinical management, and emerging therapies. The program also provides perspectives on the impact of cancer on the lives of patients and families. The 2019 conference goal is to inform, update, and improve practitioners’ understanding of existing and emerging immunologic therapies for cancer. The theme of the afternoon patient program is Hopefulness During Change, Aging, Illness and Loss.

TARGET AUDIENCE

The target audience for this conference is hematologists, oncologists, nurse practitioners, physician assistants, oncology nurses, family, and primary care practitioners, allied health professionals, and any other interested cancer care providers. Healthcare professionals are welcome and encouraged to participate in the afternoon patient-centered sessions.

Healthcare professionals are welcome and encouraged to participate in the afternoon patient-centered sessions.

AGENDA

LEARNING OBJECTIVES

After completing this activity, participants should be better prepared to:

Review the basic science of the immune system interactions with cancer
Discuss the existing and emerging data on checkpoint inhibition therapy
Evaluate a variety of historical, contemporary and emerging immunotherapy approaches through the paradigm of cutaneous melanoma
Describe the evolving paradigms and data on allogeneic hematopoietic stem cell transplantation
Review the data on current and emerging Chimeric Antigen Receptor T cell (CAR-T) and other cellular therapy constructs

PLANNING COMMITTEE

Ira Zackon, MD (Chair)

Medical Hematology and Oncology Director
NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH
Clinical Assistant Professor
Albany Medical College
Albany, NY

Edward Dick, LCSW

Clinical Social Worker
NYOH Consultant
Albany, NY

Courtney Bellomo, MD

NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH
Clinical Assistant Professor
Albany Medical College
Albany, NY

Mary Jo Tomlinson, RN, BSN, OCN

Stem Cell Transplant
NYOH
Albany, NY

Guest Faculty

Marc S. Ernstoff, MD

Professor & Katherine Anne Gioia Chair of Medicine
Senior Vice President for Clinical Investigation
Roswell Park Comprehensive Cancer Center
Elm & Carlton
Buffalo, NY

Sarah Nikiforow, MD, PhD

Clinical Instructor, Stem Cell Transplantation Program
Asst. Medical Director, Cell Manipulation Core Facility
Dana-Farber Cancer Institute
Boston, MA

Faculty

Michael D. Robek, PhD

Professor
Department of Immunology & Microbial Disease
Albany Medical College
Albany, NY

Stephen H. Wrzesinski MD, PhD

Director of Immunooncology and Cellular Therapies
New York Oncology Hematology
Clinical Assistant Professor of Medicine
Albany Medical Center
Albany, NY

Ira Zackon, MD (Chair)

Medical Hematology and Oncology Director
NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH
Clinical Assistant Professor
Albany Medical College
Albany, NY

Disclosure of Faculty Financial Interest or Relationships

It is the policy of the Center for Emergency Medical Education (CEME) to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities, and that all contributors present information in an objective, unbiased manner without endorsement or criticism of specific products or services and that the relationships that contributors disclose will not influence their contributions. In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Center for Emergency Medical Education (CEME) requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias. All individuals in a position to control the content of this CME activity have indicated that he/she has no relevant financial relationships, which, in the context of this CME activity, could be perceived as a potential conflict of interest. Complete disclosure of relevant (or no) financial relationships will be made to learners prior to the beginning of the CME activity. All faculty pictured may not be at all scheduled course dates.

Venue

Albany Marriott Hotel
189 Wolf Road
Albany, NY 12205
518-458-8444

Overnight accommodations at the Albany Marriott Hotel are offered at a special rate of $134/night. Hotel rooms are blocked for the night of May 10, 2019, only. The hotel will extend the negotiated rate to the nights before and after the conference based upon availability.

Make your reservation

You may also call the hotel directly to make your reservation at 518-458-8444 and mention Group Code: Med Ed.

Reservations must be made by April 19, 2019, to receive the special rate.

Event staff will be glad to assist you with any special needs (physical, dietary, etc.).

Complimentary parking is available.

Host

The 6th Annual Spring to Life™ Conference on Immuno-Oncology:
Harnessing the Power of our Immune System in Cancer Therapy is proudly hosted by

New York Oncology Hematology, PC

ACCREDITATION

Physician and Allied Health Professional Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Center for Emergency Medical Education and myMedEd, Inc.

The Center for Emergency Medical Education (CEME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Center for Emergency Medical Education (CEME) designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Center for Emergency Medical Education (CEME) designates this live activity for a maximum of 3.75 hours of participation for continuing education for allied health professionals.

Nurse and Social Worker Accreditation

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 3.75 continuing education contact hours through the California Board of Registered Nursing. This document must be retained by the licensee for a period of four years after the course ends.

The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: 12/10/2017 to 12/10/2020. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 3.75 CE (clinical) contact hours.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 3.75 CE (clinical) contact hours for this activity.

ACCREDITED PROVIDERS

This Activity Is Planned By myMedEd, Inc.

Accredited Provider: